SPONSOR

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Total Trials

Recruiting

Phases

N/A

Conditions studied: Cerclage, Cervical HCC - Hepatocellular Carcinoma Renal Artery Stenosis Heart Transplantation Preeclampsia Hypertensive Disorder of Pregnancy Rejection; Transplant, Liver Bronchiectasis Adult Hepatic Cancer Hepatic Resection

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a clinical research sponsor with 31 registered studies on ClinicalTrials.gov, of which 31 are actively recruiting participants. Research covers conditions including Cerclage, Cervical, HCC - Hepatocellular Carcinoma, Renal Artery Stenosis, Heart Transplantation.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — IRCCS Azienda Ospedaliero-Universitaria di Bologna

How many clinical trials has IRCCS Azienda Ospedaliero-Universitaria di Bologna sponsored?

ClinicalMetric currently tracks 31 clinical trials sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna, of which 31 are actively recruiting participants. These trials cover conditions including Cerclage, Cervical, HCC - Hepatocellular Carcinoma, Renal Artery Stenosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does IRCCS Azienda Ospedaliero-Universitaria di Bologna research focus on?

IRCCS Azienda Ospedaliero-Universitaria di Bologna clinical trials span Cerclage, Cervical, HCC - Hepatocellular Carcinoma, Renal Artery Stenosis, Heart Transplantation, Preeclampsia, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.

How do I participate in a IRCCS Azienda Ospedaliero-Universitaria di Bologna clinical trial?

To participate in a IRCCS Azienda Ospedaliero-Universitaria di Bologna trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all IRCCS Azienda Ospedaliero-Universitaria di Bologna trials with current recruitment status updated daily.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Frequently Asked Questions — IRCCS Azienda Ospedaliero-Universitaria di Bologna

Clinical Trials by IRCCS Azienda Ospedaliero-Universitaria di Bologna

Comparison of Cervical Cerclage by Vaginal and by Laparoscopic Transabdominal Routes in the Periconceptional Period

Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?

Identification and Treatment of Renal Stenosis in Transplanted Kidneys

Precision Medicine in the Management of Heart Transplant Recipients

Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy

Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation

Comparison Between Conventional Respiratory Physiotherapy and the Simeox Device in Patients With Bronchiectasis

Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation

Electronic Register on Advanced Heart Failure and Transplantation di Cuore

Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

How Nocturnal Hypoventilation Predicts Long-term Response to Non-invasive Ventilation in Hypercapnic COPD Patients

Survey for Parental Perception of Procedural Analgosedation in Pediatric Age.

Neonatal Screening of Biotinidase Deficiency: Genotype-phenotype Correlation and Clinical Follow-up

Latissimus Dorsi Flap Reconstructions: Retrospective Study

Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer

Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation

Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid

Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft

Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia

Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients

The Effect of Ultrasound Visual Feedback on Birth Outcomes in Nulliparous Women With Levator Ani Muscle Co-activation at Term Pregnancy

ASSESSMENT OF THE NATURAL HISTORY AND PROGNOSTIC FACTORS OF THERAPEUTIC RESPONSE IN SUB-PHENOTYPES OF PATIENTS WITH OBESITY: THE BOLOBE STUDY

Insights on Dissemination of Lung Cancer

Study of the Characteristics of the Vascular Wall in Pediatric Age

Early Identification of Cardivascular Damage Induced by Chemotherapy and Antineoplastic Treatments in Pediatric Age

Nephrological Outcome and Associated Congenital Anomalies in Pediatric Patients with Horseshoe Kidney

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

Implementation of the Methylome in the Characterization of Solid Tumors

Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects

Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas